PMC:7344504 / 8770-8987 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T20","span":{"begin":73,"end":77},"obj":"Body_part"}],"attributes":[{"id":"A20","pred":"fma_id","subj":"T20","obj":"http://purl.org/sig/ont/fma/fma74402"}],"text":"t was changed to liposomal amphotericin B 200 mg q24h. Subsequent cyp51A gene sequencing identified a TR34/L98H mutation, probably responsible for the observed azole resistance. On day 22, ventilation and oxygenation "}

{"project":"LitCovid-PubTator","denotations":[{"id":"237","span":{"begin":27,"end":41},"obj":"Chemical"},{"id":"238","span":{"begin":160,"end":165},"obj":"Chemical"},{"id":"239","span":{"begin":107,"end":111},"obj":"Mutation"}],"attributes":[{"id":"A237","pred":"tao:has_database_id","subj":"237","obj":"MESH:D000666"},{"id":"A238","pred":"tao:has_database_id","subj":"238","obj":"MESH:D001393"},{"id":"A239","pred":"tao:has_standard_notation","subj":"239","obj":"p.L98H"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"t was changed to liposomal amphotericin B 200 mg q24h. Subsequent cyp51A gene sequencing identified a TR34/L98H mutation, probably responsible for the observed azole resistance. On day 22, ventilation and oxygenation "}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T57","span":{"begin":40,"end":41},"obj":"http://purl.obolibrary.org/obo/CLO_0001021"},{"id":"T58","span":{"begin":73,"end":77},"obj":"http://purl.obolibrary.org/obo/OGG_0000000002"},{"id":"T59","span":{"begin":100,"end":101},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T60","span":{"begin":185,"end":187},"obj":"http://purl.obolibrary.org/obo/CLO_0050507"}],"text":"t was changed to liposomal amphotericin B 200 mg q24h. Subsequent cyp51A gene sequencing identified a TR34/L98H mutation, probably responsible for the observed azole resistance. On day 22, ventilation and oxygenation "}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T70","span":{"begin":27,"end":41},"obj":"Chemical"},{"id":"T71","span":{"begin":160,"end":165},"obj":"Chemical"}],"attributes":[{"id":"A70","pred":"chebi_id","subj":"T70","obj":"http://purl.obolibrary.org/obo/CHEBI_2682"},{"id":"A71","pred":"chebi_id","subj":"T71","obj":"http://purl.obolibrary.org/obo/CHEBI_68452"}],"text":"t was changed to liposomal amphotericin B 200 mg q24h. Subsequent cyp51A gene sequencing identified a TR34/L98H mutation, probably responsible for the observed azole resistance. On day 22, ventilation and oxygenation "}

{"project":"LitCovid-sentences","denotations":[{"id":"T75","span":{"begin":55,"end":177},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"t was changed to liposomal amphotericin B 200 mg q24h. Subsequent cyp51A gene sequencing identified a TR34/L98H mutation, probably responsible for the observed azole resistance. On day 22, ventilation and oxygenation "}